Literature DB >> 10986861

Placental transfer of IgG subclasses in a Japanese population.

S Hashira1, S Okitsu-Negishi, K Yoshino.   

Abstract

BACKGROUND: Maternal immunoglobulin G (IgG), transferred across the placenta to the fetus during intrauterine life, is an important component of the neonatal immunological defence mechanisms against infection. There is controversy with respect to differences in placental transfer of the different IgG subclasses, and no definite data are available on a Japanese population. Therefore, we investigated placental transfer of IgG subclasses in a Japanese population.
METHODS: A total of 228 matched pairs of cord and maternal serum samples (20-42 weeks gestation) were assayed for each IgG subclass by an enzyme-linked immunosorbent assay.
RESULTS: The mean values and hierarchy of cord/maternal concentration ratios of IgG subclasses at 40 weeks gestation were as follows: IgG1(1.47) > IgG3(1.17) = IgG4(1.15) > IgG2(0.80). The cord/maternal concentration ratios of all IgG subclasses were positively correlated to gestational age. The mean ratios for IgG1 and IgG4 nearly reached a plateau at 39 and 37 weeks gestation, respectively, while those for IgG2 and IgG3 increased until 41 weeks gestation. The ratios of all IgG subclasses for full-term deliveries were reciprocally correlated to the respective maternal IgG subclass serum levels.
CONCLUSIONS: The results suggest that although all four IgG subclasses are actively transferred across the placenta, the efficiency of their transfer ranks in the order IgG1 > IgG3 = IgG4 > IgG2. The different results as to placental transfer of IgG subclasses in the literature might be due, at least in part, to different maternal IgG subclass serum levels in the populations studied.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986861     DOI: 10.1046/j.1442-200x.2000.01245.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  27 in total

Review 1.  Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature?

Authors:  D Lindfield; K Attfield; A McElvanney
Journal:  Eye (Lond)       Date:  2012-02-03       Impact factor: 3.775

2.  Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.

Authors:  P Plans; F de Ory; M Campins; E Álvarez; T Payà; E Guisasola; C Compte; K Vellbé; C Sánchez; M J Lozano; I Aran; A Bonmatí; R Carreras; M Jané; L Cabero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-10       Impact factor: 3.267

3.  Placental Transfer of Canakinumab in a Patient with Muckle-Wells Syndrome.

Authors:  Makiko Egawa; Kohsuke Imai; Masaaki Mori; Naoyuki Miyasaka; Tetsuo Kubota
Journal:  J Clin Immunol       Date:  2017-04-06       Impact factor: 8.317

4.  Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality.

Authors:  Caitlin Milligan; Barbra A Richardson; Grace John-Stewart; Ruth Nduati; Julie Overbaugh
Journal:  Cell Host Microbe       Date:  2015-04-08       Impact factor: 21.023

5.  Predicting the HILIC Retention Behavior of the N-Linked Glycopeptides Produced by Trypsin Digestion of Immunoglobulin Gs (IgGs).

Authors:  Majors J Badgett; Emily Mize; Tyler Fletcher; Barry Boyes; Ron Orlando
Journal:  J Biomol Tech       Date:  2018-12

Review 6.  Eculizumab in pregnancy: a narrative overview.

Authors:  Laura Sarno; Antonella Tufano; Giuseppe Maria Maruotti; Pasquale Martinelli; Mario M Balletta; Domenico Russo
Journal:  J Nephrol       Date:  2018-08-29       Impact factor: 3.902

Review 7.  Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.

Authors:  Naoyuki Miyasaka; Osamu Miura; Tatsuya Kawaguchi; Nobuyoshi Arima; Eriko Morishita; Kensuke Usuki; Yasuyoshi Morita; Kaichi Nishiwaki; Haruhiko Ninomiya; Akihiko Gotoh; Shinsaku Imashuku; Akio Urabe; Tsutomu Shichishima; Jun-Ichi Nishimura; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2016-02-08       Impact factor: 2.490

8.  Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream.

Authors:  Naoki Nozawa; June Fang-Hoover; Takako Tabata; Ekaterina Maidji; Lenore Pereira
Journal:  J Clin Virol       Date:  2009-10-24       Impact factor: 3.168

9.  Efficiency of placental transfer of vaccine-elicited antibodies relative to prenatal Tdap vaccination status.

Authors:  Annalisa L Post; Shuk Hang Li; Madison Berry; Hannah Itell; David R Martinez; Guanhua Xie; Sallie R Permar; Geeta K Swamy; Genevieve G Fouda
Journal:  Vaccine       Date:  2020-05-29       Impact factor: 3.641

10.  Deficit of IgG2 in HIV-positive pregnant women is responsible of inadequate IgG2 levels in their HIV-uninfected children in Malawi.

Authors:  Silvia Baroncelli; Clementina Maria Galluzzo; Giuseppe Liotta; Mauro Andreotti; Sandro Mancinelli; Robert Mphwere; Enok Bokola; Roberta Amici; Maria Cristina Marazzi; Leonardo Palombi; Francesca Lucaroni; Marina Giuliano
Journal:  Med Microbiol Immunol       Date:  2018-02-27       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.